One conviction:
diagnose earlier, save lives.
The death rate has been rising longer than any other women’s cancer.1
Uterine cancer
has been left behind.
Breast cancer has the mammogram. Cervical cancer has the Pap smear. Decades of awareness, research, and clinical advancement have transformed how we catch both — earlier, more reliably, more routinely.
Endometrial cancer hasn’t followed that story. It has long been perceived as lower risk — but mortality is rising. It’s increasingly affecting younger women, with rising rates of more aggressive subtypes and evolving risk factors.123 And the tools clinicians rely on today weren't designed for earlier detection — or to detect abnormalities before symptoms appear at all.
We built one that will.
The people who refused
to
accept the standard
We envision a world where endometrial cancer
is caught before symptoms appear
We’re championing a new standard of care where every woman knows her risk and has access to early diagnosis. Here’s how we’re getting there:
Ensure every symptomatic woman gets an accurate diagnosis the first time
Expand access to early detection for high-risk women, before symptoms appear
Change the guidelines. Make routine endometrial screening standard practice.
The Eva Tucci Foundation
Utepreva and the Eva Tucci Foundation exist together as a statement of intent: changing and preventing outcomes for women requires more than a better device. It requires the research, awareness, and advocacy to match.
Try Utepreva in your practice
And improve endometrial cancer diagnoses, one sampler at a time.
A better way to diagnose endometrial cancer is here.